Flumatinib is a tyrosine kinase inhibitor and it’s a second-generation TK inhibitor drug against Bcr
READ MORE 2019-11-19News List
Hansoh pharm's first sorts of new medicine "Flumatinib" will be approved for listing
FDA approves Lilly Reyvow
Recently, Lilly announced that the US FDA approved the company's development of Reyvow (lasmidit
READ MORE 2019-10-20
The third anti-tb drug was approved by the FDA
On August 14th, the FDA approved TB Alliance new fluorine-containing anti-tuberculosis drug Pretoman
READ MORE 2019-09-23
Holiday Notice of Mid-Autumn Festival
To all departments and all employees:According to the related provisions on national holidays &
READ MORE 2019-09-10
CPhI North America 2020 in Philadelphia USA Booth#1506
FluoroPharm will exhibit CPhI North America 2020 in Pennsylvania Convention Center,Philadelphia, PA,
READ MORE 2019-08-26
FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor
The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib),
READ MORE 2019-08-19
The 150 millionth chemical substance was born!
According to the American Chemical and Engineering News (C&EN), the American Chemical Abstracts
READ MORE 2019-08-07
FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray® (alpelisib)
READ MORE 2019-07-11
New drug delivery method, FDA approved a new epilepsy treatment
UCB announced that the USFDA has approved Nayzilam (midazolam) nasal spray for the acute treatment o
READ MORE 2019-06-28
Holiday Notice of Dragon Boat Festival
To all departments and employees:According to the related national legal & the actual situation
READ MORE 2019-05-31